U.S. Pharmacist

• Newly Approved HIV Medications Review the novel antiretroviral drugs and drug combinations which have been recently approved for the treatment of HIV.
  U.S. Pharmacist, December 29, 2020
• The Effect of COVID-19 on Patients With Diabetes This article explores potential mechanisms associated with increased risk of negative COVID-19 outcomes in patients with diabetes, and the impact of comorbidities in these patients.
  U.S. Pharmacist, December 22, 2020
• Human Papillomavirus (HPV) Vaccine Update Review the latest ACIP recommendations regarding the HPV vaccine, as well as its safety profile, in this primer.
  U.S. Pharmacist, December 15, 2020
• Pharmacotherapy in Hospitalized Patients With COVID-19 Pneumonia While pharmacotherapy in COVID-19 is constantly evolving, this article summarizes general recommendations based on current best evidence for support of hospitalized patients with COVID-19 pneumonia.
  U.S. Pharmacist, September 25, 2020
• Discussing Brand Versus Generic Medications Many patients remain resistant to using generic medications. This article outlines discussion points and resources to educate patients and help overcome barriers to their use of generic drugs.
  U.S. Pharmacist, August 11, 2020
• Managing Treatment-Resistant Depression Nearly 25% of patients may have an inadequate response to depression therapy. Review the diagnosis and available therapeutic options for treatment-resistant depression in this article.
  U.S. Pharmacist, July 28, 2020
• Understanding Antimicrobial Resistance Which bacteria are considered the most threatening resistant organisms in the U.S.? Learn about their mechanisms of resistance and new antibiotics to combat them in this review.
  U.S. Pharmacist, June 12, 2020
• Pharmacist's Guide to CBD Oil Cannabidiol, or CBD, is becoming more readily available and gaining popularity in the U.S. What should you know in order to counsel patients effectively regarding legalities, indications, and usage?
  U.S. Pharmacist, June 05, 2020
• Antiarrhythmic Treatment in Atrial Fibrillation Review the various types of antiarrhythmic agents used in the treatment of atrial fibrillation in this primer. How should the selection of an appropriate drug be made?
  U.S. Pharmacist, May 29, 2020
• An Overview of New Biologics for Migraine Prophylaxis Review what you need to know regarding the three calcitonin CGRP antagonists which were recently FDA approved for prophylactic treatment of migraine.
  U.S. Pharmacist, March 30, 2020
• Appropriate Use and Stewardship of Proton-Pump Inhibitors While proton-pump inhibitors are effective for a wide variety of conditions, they are not without risk, especially when used long-term. Review their appropriate and inappropriate use in this article.
  U.S. Pharmacist, January 31, 2020
• Alcohol Withdrawal in the Inpatient Setting This review explores a variety of pharmacologic options for treatment of alcohol withdrawal syndrome in hospitalized patients.
  U.S. Pharmacist, January 24, 2020
• Avoiding Drug-Induced Hypoglycemia in the Older Adult Many medications have the potential to induce hypoglycemia, especially in the older patient. Review the signs and symptoms of drug-induced hypoglycemia as well as the common culprits in this article.
  U.S. Pharmacist, January 10, 2020
• OTC Medication Use in Pregnancy and Breastfeeding Which over-the-counter medications are safe to use during pregnancy or the breastfeeding period?
  U.S. Pharmacist, November 22, 2019
• Testosterone Replacement Therapy: Controversy and Trends The use of testosterone replacement therapy remains controversial. What does the current literature tell us about risks and benefits of this treatment?
  U.S. Pharmacist, November 08, 2019
• Severe Asthma: An Update for 2019 This review focuses on the management of patients presenting with acute, poorly controlled asthma, highlighting therapeutic options for acute exacerbations and prevention.
  U.S. Pharmacist, September 05, 2019
• Overcoming Barriers to Statin Adherence Poor adherence can be a significant barrier to effective statin therapy. What steps can be taken to improve adherence and manage intolerance and other adverse effects?
  U.S. Pharmacist, July 26, 2019
• Anticoagulation in Pediatrics: DOACs on the Horizon DOACs have not yet been approved for pediatric use. This article reviews current studies and what you should know regarding selecting appropriate anticoagulation therapy for children.
  U.S. Pharmacist, July 02, 2019
• Updates in the Management of Clostridium difficile for Adults This article reviews recent guideline updates for the treatment of C. difficile infection, which reflect significant changes from previous recommendations.
  U.S. Pharmacist, June 18, 2019
• OTC Transdermal Analgesic Patches in Pain Management Review the use of over-the-counter transdermal pain patches in this article. Which types are most effective, and how should you counsel patients on their proper use?
  U.S. Pharmacist, May 22, 2019